日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

西妥昔单抗和纳武利尤单抗治疗复发/转移性头颈癌的 II 期临床试验的长期生存率和分子生物标志物评估。

Chaudhary Ritu, Moorhead Graydon, Park Robin, Li Jiannong, Schell Michael J, Song Xiaofei, Tan AikChoon, Slebos Robbert J C, Biernacki Maria I, Freeman Samuel S, Thatikonda Sowjanya, Meshkovska Yeva, Hernandez-Prera Juan, Kirtane Kedar, Guevara-Patino Jose A, Amelio Antonio L, Rocco James W, Danysh Brian P, Bonomi Marcelo, Saba Nabil F, Haradhvala Nicholas J, Getz Gad, Chung Christine H

Selection Criteria for De-Escalated Chemoradiotherapy for HPV-Related Oropharyngeal Cancer Based on Prognostic Biomarkers or Early Tumor Response to Therapy: A Narrative Review

基于预后生物标志物或早期肿瘤治疗反应的HPV相关口咽癌降阶梯放化疗选择标准:叙述性综述

Eisbruch, Avraham; Sreeram, M P; Rao, Karthik; Agaimy, Abbas; Kowalski, Luiz P; Pelaz, Andrés Coca; Araújo, Anna Luíza Damaceno; Guntinas-Lichius, Orlando; Rodrigo, Juan P; Lopez, Fernando; Nuyts, Sandra; Saba, Nabil F; Forastiere, Arlene; Bradford, Carol R; Ferlito, Alfio

Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial

在II期临床试验中,对接受西妥昔单抗和纳武利尤单抗联合治疗的复发和/或转移性头颈部鳞状细胞癌患者的中性粒细胞与淋巴细胞比值进行评估

Park, Robin; Rind, Fahad; Kristoff, Tyler; Li, Jiannong; Schell, Michael; Slebos, Robbert J C; Thatikonda, Sowjanya; Chaudhary, Ritu; Biernacki, Maria I; Meshkovska, Yeva; Kaldas, David; Kim, Hyun-Su; Farinhas, Joaquim; Hernandez-Prera, Juan; Kirtane, Kedar; Hall, MacLean S; Amelio, Antonio L; Rocco, James W; Bhateja, Priyanka; Steuer, Conor; Bonomi, Marcelo; Saba, Nabil F; Chung, Christine H

Inhibiting FAT1 Blocks Metabolic Bypass to Enhance Antitumor Efficacy of TCA Cycle Inhibition through Suppressing CPT1A-Dependent Fatty Acid Oxidation.

抑制 FAT1 可阻断代谢旁路,通过抑制 CPT1A 依赖性脂肪酸氧化来增强 TCA 循环抑制剂的抗肿瘤功效

Chen Fanghui, Yang Jianqiang, Popoola David O, Yang Fan, Liu Yajie, Wang Dongsheng, Qin Zhaohui S, Chen Zhengjia, Saba Nabil F, Chen Zhuo G, Li Yamin, Teng Yong

Tumor secretome shapes the immune landscape during cancer progression

肿瘤分泌组在癌症进展过程中塑造免疫微环境

Yang, Jianqiang; Tang, Sijia; Saba, Nabil F; Shay, Chloe; Teng, Yong

Blocking the TCA Cycle in Cancer Cells Potentiates CD36+ T-cell-Mediated Antitumor Immunity by Suppressing ER Stress-Associated THBS2 Signaling

阻断癌细胞中的三羧酸循环可通过抑制内质网应激相关的THBS2信号通路增强CD36+ T细胞介导的抗肿瘤免疫。

Jianqiang Yang # ,Fanghui Chen # ,Zhenzhen Fu ,Fan Yang ,Nabil F Saba ,Yong Teng

Dual CDK and MEK Inhibition potentiates CD8+ T cell-mediated antitumor immunity by inducing pyroptotic cell death in high-mutational head and neck cancer

双重 CDK 和 MEK 抑制通过诱导高突变头颈癌细胞发生焦亡来增强 CD8+ T 细胞介导的抗肿瘤免疫。

Fanghui Chen #,Fang Yang #,David O Popoola,Jianqiang Yang,Chris Tang,Alexis Payne,Lynn Zhang,Nicole C Schmitt,Jin Xie,Nabil F Saba,Yamin Li,Yong Teng

Dual CDK and MEK Inhibition potentiates CD8+ T cell-mediated antitumor immunity by inducing pyroptotic cell death in high-mutational head and neck cancer

CDK 和 MEK 双重抑制通过诱导高突变头颈癌细胞发生焦亡,增强 CD8+ T 细胞介导的抗肿瘤免疫。

Fanghui Chen # ,Fang Yang # ,David O Popoola ,Jianqiang Yang ,Chris Tang ,Alexis Payne ,Lynn Zhang ,Nicole C Schmitt ,Jin Xie ,Nabil F Saba ,Yamin Li ,Yong Teng

Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163

新辅助化疗联合手术与器官保留手术治疗T3和T4a期鼻及鼻窦鳞状细胞癌的比较:ECOG-ACRIN EA3163

Saba, Nabil F; Flamand, Yael; Lin, Derrick T; Chung, Christine H; McDonald, Mark W; Flampouri, Styliani; Khan, Saad A; Snyderman, Carl H; Hanna, Ehab Y; El-Sayed, Ivan H; Solares, Clementino A; Le, Christopher H; Ghaly, Maged; Hwang, Peter H; Shin, Dong M; Axelrod, Rita S; Ikpeazu, Chukwuemeka V; Adkins, Douglas R; Duan, Fenghai; Cohen, Marc; Samuels, Michael A; Swiecicki, Paul L; Subramaniam, Rathan M; Chakravarthy, A Bapsi; Burtness, Barbara A

Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer

早期临床试验:IAP拮抗剂托利那泮联合根治性放疗治疗不适合顺铂治疗的晚期头颈癌患者

Schmitt, Nicole C; Stokes, William A; Bates, James E; Kinney, Brendan L C; Remick, Jill; McDonald, Mark W; Rudra, Soumon; Steininger, Madison; Oyewole, Mosope; Patel, Mihir R; Kaka, Azeem S; Gross, Jennifer H; Switchenko, Jeffrey; Steuer, Conor E; Shin, Dong M; Saba, Nabil F